Course Description
This course reflects current industry trends and challenges for the more experienced monitor/clinical research associate – with a focus on developing tools and identifying challenges for effective monitoring. Industry standards and best practices will be discussed with an emphasis on the relationship between the Sponsor/CRO and the Investigator/site personnel. References and resources (including those available online) will be provided. Topics include site management, developing tools for effective monitoring, co-monitoring assessments, monitoring plan development best practices, and successful time management. Discussion will include how sponsors/CROs interpret and implement various aspects of clinical trials and GCP principles.
Learning Objectives
Who Should Attend
Instructor
The course will be led by one of the following instructors:
Nikki Christison, B.S., C.C.R.A.,T.I.A.C.R.
Sonja Cooper, Ph.D., M.B.A.
Janet Ellen Holwell, C.C.R.C., C.C.R.A., T.I.A.C.R., F.A.C.R.P.
Lily Romero, P.A., C.C.R.C.
Elizabeth Weeks-Rowe, LVN, C.C.R.A.
Click here for complete trainer biographies
Course Outline
Day One
Day Two
Interactive Activities
Registration Fees
Special rates are available for multiple attendees from the same organization. Please contact Barnett Customer Service at +1 781.972.5400 or toll-free in the U.S. 800.856.2556 for more information. Or email Customer Service at: customer.service@barnettinternational.com.
Accreditation Information
Barnett International is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Participants will receive 15 hours (1.5 CEUs) of continuing education credit for full participation, including the completion of a pre-test, post-test, and program evaluation. Barnett International will issue a receipt of completion for earned CEUs within three weeks of program completion. ACPE#: 0778-0000-24-005-L99-P. Released: 3/24.
Hold
this course at your company! For more information, contact Naila Ganatra at +1
215.413.2471.